• previous post: IDSA Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections
• next post: Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections